BRETEC — Bioretec Oy Share News
0.000.00%
Last trade - 00:00- €28.71m
- €16.69m
- €3.52m
Brief: Bioretec Gets Marketing Authorization From FDA
Brief: Bioretec Receives FDA 510(K) Clearance For Its Activascrew Cannulated Com Bioabsorbable Compression Screw
Finland's Bioretec H1 revenue rises 12%, loss narrows
Brief: Bioretec Q2 Net Sales EUR 1.1 Million
Brief: Panu Mikkonen Appointed As Chief Financial Officer Of Bioretec
Brief: Bioretec CFO Paavola To Leave Company
Brief: Bioretec Concludes Change Negotiations
Manager's Transactions - Jordy Winters
Manager's Transactions - Jordy Winters
Brief: Bioretec Initiates New Change Negotiations In Production To Enhance Operational Efficiency
Finland's Bioretec Q1 revenue falls
Brief: Bioretec Q1 EBITDA EUR -1.375 Million
Brief: Bioretec Clarifies Its 2026-2028 Financial Target Regarding The Sales Margin
Brief: Bioretec Clarifies 2026-2028 Financial Target Regarding Sales Margin
Brief: Bioretec Says 1.29 Bln New Shares Were Subscribed For In Rights Issue
Brief: Bioretec Announces Preliminary Results From Rights Issue
Brief: Bioretec Resolves On Rights Issue Of Up To About EUR 14.8 Mln
Brief: Bioretec Resolves On Rights Issue Of Up To About EUR 14.8 Mln
Brief: Bioretec Oy - Finnish FSA Grants Permanent Exemption From Mandatory Takeover Bid To Stephen Industries Inc Oy